Table 3.
Extracts/constituents | Doses | Model of study | Effects | References |
---|---|---|---|---|
Aqueous, methanolic, and ethanolic extracts | In vitro | ↑ DPPH scavenging capacity and FRAP | [115] | |
Aqueous extracts of leaves, stems, and flowers | In vitro | ↑ DPPH scavenging capacity | [116] | |
Aqueous and ethanolic extracts | 100–400 µg/ml | Free radical-induced hemolysis of RBCs in rats | ↓ Rate of AAPH-induced hemolysis | [127] |
1200, 1800 µg/ml | ↑ Lag time of AAPH-induced hemolysis | |||
↓ RBC damages | ||||
Ethanolic extract of leaves | In vitro | ↑ ABTS and DPPH scavenging capacity | [117] | |
Methanolic extract | In vitro | ↑ DPPH scavenging capacity | [118] | |
Methanolic extract | In vitro | ↑ DPPH scavenging capacity | [119] | |
↓ Lipid peroxidation | ||||
Methanolic extract of leaves | In vitro | ↑ DPPH scavenging capacity | [120] | |
Inhibition ratio of the linoleic acid oxidation | ||||
Methanolic extract | In vitro | ↑ Electron donating ability and SOD-like ability | [121] | |
Fresh and dried hydroalcoholic extracts | In vitro | ↑ ABTS and DPPH scavenging capacity | [122] | |
Fresh and dried leaves | In vitro | ↑ ABTS and DPPH scavenging capacity | [123] | |
Five fractions obtained from the crude extract | In vitro | ↑ Trolox equivalent antioxidant capacity (TEAC) | [124] | |
↓ Lipid peroxidation | ||||
Aqueous juice | 1.5 ml/kg, orally for 12 days | Normal rats | ↓ Hepatic and renal MDA | [114] |
↓ Testicular nitrite/nitrate | ||||
↑ Hepatic and testicular GSH | ||||
↑ Hepatic, renal, and testicular SOD and CAT | ||||
Aqueous extract | 100 and 200 mg/kg, intragastrically | High-fat diet-induced mice | ↓ Blood TBARS | [125] |
↑ Blood GSH | ||||
↑ Blood and liver SOD, CAT, and GPx | ||||
↓ Liver ALT and AST | ||||
Aqueous extract | 300 mg/kg, intragastrically for 5 days | Renal ischemia reperfusion injury (IRI) in rats | ↓ ALT, ALP, and LDH | [126] |
Ethanolic extract | 0.01, 0.05, 0.1, and 0.15 g/kg, intragastrically for 30 days | Carbon tetrachloride (CCl4)-induced hepatic toxicity in rats | ↓ ALT, AST, ALP, and GGT | [128] |
↑ SOD | ||||
Ethanolic extract of leaves | 25, 50, and 100 mg/kg, orally | Alcoholic liver disease rat's model | ↓ AST, ALT, ALP, and GGT | [117] |
↓ TBARS and lipid hydroperoxides | ||||
↑ Vitamin C, vitamin E, and GSH | ||||
↑ SOD, CAT, GPx, and GST | ||||
Ethanolic extract | 4 mg/kg, orally | Neurotoxicity induced by MeHg in cerebellum and cortex of rats | ↓ TBARS | [129] |
↑ GSH, GPx, CAT, and SOD | ||||
Fresh and dried leaves | 200 and 400 mg/kg, orally for 3 weeks | STZ-induced C57BL/6J diabetic mice | ↓ MDA | [130] |
↑ SOD | ||||
Fresh juice | 300 mg/kg, orally | Paracetamol-induced hepatic toxicity in rats | ↓ Hepatic TBARS content | [131] |
↑ GSH, CAT, and SOD | ||||
Hydroethanolic extract | 1, 2, and 4 mg/mL | Asthmatic rat model | ↓ MDA | [132] |
↑ SOD, CAT, and thiol | ||||
Purslane ethanolic extract and chicory water extract | 100 mg/kg for each | Glucocorticoid-induced testicular and autophagy dysfunction in rats | ↓ MDA | [133] |
↑ GSH, GST, and GPx | ||||
Seed extract | 200 and 400 mg/kg | Acrylamide-induced testicular toxicity in rats | ↑ SOD and GSH | [134] |
↓ MDA | ||||
Hydroalcoholic extract | 25, 50, and 100 mg/L | In vitro | ↓ Intracellular ROS | [135] |
↑ Motility of sperm | ||||
Hydroalcoholic extract | 400 mg/kg | Thyrotoxic rat model | ↑ Thiol, SOD, and CAT | [136] |
↓ MDA | ||||
Plant sterol ester of α-linolenic acid (PS-ALA) | 0.1 mM PS-ALA | HepG2 cells induced by oleic acid | ↓ ROS production | [137] |
ALA | 1, 10, 33, 49, and 64%, orally for 21 days | Rats fed sunflower, canola, rosa mosqueta, and sacha inchi oils | ↑ GSH and GSSG, hepatic and plasma content of protein carbonyls, F-2 isoprostanes, TBARS, SOD, CAT, GPx, and GR | [138] |
ALA | 150 μg/kg | Amyloid-beta peptide-induced oxidative stress in rats | ↓ MDA and NO | [139] |
↑ CAT activity and glutathione content in hippocampus | ||||
Quercetin | Iron-loaded hepatocyte cultures in vitro | ↓ MDA and LDH | [140] | |
Quercetin | 2.5, 5 and 7.5 µM | Copper-catalysed human LDL oxidation in vitro | ↓ LDL oxidation | [141] |
Quercetin | Human erythrocytes in vitro | ↓ lipid peroxidation, hemolysis, and GSH | [142] | |
Quercetin | 50 or 100 µM | Glucose oxidase-mediated apoptosis | ↓ NF-kappaB, AP-1, and p53 | [143] |
Quercetin | 10, 20, 50, 100, or 1000 µM | In vitro | ↓ Hydroperoxides | [144] |
Quercetin | In vitro | ↑ FRAP and ABTS | [145] | |
Quercetin-loaded nanoparticles | In vitro | ↑Anti-superoxide formation and DPPH scavenging capacity | [146] | |
↓ Superoxide anion | ||||
Quercetin-loaded nanoparticles | In vitro | ↑ DPPH scavenging capacity | [147] | |
Quercetin | 2%, orally for 21 days | Rats adapted to a semipurified diet supplemented with quercetin | ↑ ABTS | [148] |
Quercetin | 15 mg/kg, i.p. for 4 weeks | STZ-induced diabetic rats | ↓ MDA and NO | [149] |
↑ SOD, CAT, and GPx | ||||
Quercetin | 75 mg/kg, i.p. for 10 days | Cyclophosphamide-induced hepatotoxicity in rats | ↓ MDA and PCO | [150] |
Quercetin | 50 mg/kg, for 10 days | Bile duct ligation-induced liver injury in rats | ↑ Glutathione peroxidase | [151] |
↓ Oxidation of proteins | ||||
Quercetin | 50 mg/kg, intragastrically | Normal rats | ↓ Plasma antioxidant status | [152] |
Quercetin | 10 mg/kg, i.p. for 14 days | STZ-induced diabetic rats | ↑ Brain GSH, hepatic GPx, hepatic lipid peroxidation, renal and cardiac GPx, and cardiac CAT | [153] |
↓ Hepatic GSH | ||||
Quercetin | 50 mg/kg, i.p. | Ethanol-induced gastric lesions in rats | ↓ MDA | [154] |
↑ SOD, CAT, and GPx | ||||
Quercetin | 100 mg/kg, for 14 days | Rat model of tramadol intoxication | Improved MDA, SOD, NOx in the heart, liver, adrenal, and kidney | [155] |
Quercetin | 50 mg/kg, orally | Radiation-induced hepatotoxicity and renal toxicity in rats | ↓ MDA level in the liver and kidney | [156] |
Quercetin | 10 mg/kg, gavage | Mice exposed to cigarette smoke | ↓ Inflammatory cytokines | [157] |
↑ SOD and CAT | ||||
↓ Myeloperoxidase | ||||
Quercetin | 25 mg/kg, gavage, for 40 days | Dental pulp of the streptozotocin-diabetic rats | Improved CAT, SOD1, GPX1, and TAC levels | [158] |
Seed oil | 3–20 mg/ml | In vitro | ↑ Hydroxyl free radical and DPPH scavenging capacity | [159] |
Some component of leaves | In vitro | ↑ DPPH scavenging capacity | [160] | |
Polysaccharide fractions; POP II and POP III | In vitro | ↑ Antioxidant activities in cell-free radical generating systems and cell-mediated radical generating systems | [161] | |
Polysaccharide fraction | 25 and 50 mg/kg, orally | STZ-induced diabetes in rats | ↓ TBARS | [162] |
↑ GSH, GPx, CAT, and SOD | ||||
Phenolic alkaloids: oleracein A (OA), oleracein B (OB) and oleracein E (OE) | Hydrogen peroxide-induced lipid peroxidation in rat brain | ↑ DPPH scavenging capacity | [41] | |
↓ MDA | ||||
Diet supplemented with leaves | 240 g/kg of leaves, orally | Oxidative stress induced by vitamin A deficiency in rats | ↑ DPPH scavenging capacity | [163] |
↑ GSH and GSSG |
ABTS: antioxidant capacity determined by radical cation; FRAP: ferric-reducing antioxidant power; TBARS: thiobarbituric acid reactive substances; PCO: protein carbonyl; DPPH: 1,1-diphenyl-2-picryl-hydrazyl; CAT: catalase, SOD: superoxide dismutase, MDA: malondialdehyde; GSH: glutathione; GPx: glutathione peroxidase; GR: glutathione reductase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; LDH: lactate dehydrogenase; AAPH: 2, 2′ azobis (2-amidinopropane) hydrochloride; GGT: gamma-glutamyl transferase; GSSG: glutathione disulfide; STZ: streptozotocin; ALA: alpha-linolenic acid.